9.75
price down icon0.31%   -0.03
after-market 시간 외 거래: 9.75
loading
전일 마감가:
$9.78
열려 있는:
$9.72
하루 거래량:
57,296
Relative Volume:
0.52
시가총액:
$140.58M
수익:
$166.88M
순이익/손실:
$-74.18M
주가수익비율:
-1.9231
EPS:
-5.07
순현금흐름:
$1.14M
1주 성능:
-2.60%
1개월 성능:
+3.72%
6개월 성능:
-32.90%
1년 성능:
-43.02%
1일 변동 폭
Value
$9.72
$9.93
1주일 범위
Value
$9.585
$10.17
52주 변동 폭
Value
$7.8701
$18.37

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
명칭
Anika Therapeutics Inc
Name
전화
(781) 457-9000
Name
주소
32 WIGGINS AVENUE, BEDFORD, MA
Name
직원
288
Name
트위터
Name
다음 수익 날짜
2025-03-12
Name
최신 SEC 제출 서류
Name
ANIK's Discussions on Twitter

ANIK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
9.75 141.01M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-17 개시 B. Riley Securities Buy
2024-11-01 재확인 Barrington Research Outperform
2023-08-14 업그레이드 Barrington Research Mkt Perform → Outperform
2023-03-07 다운그레이드 Barrington Research Outperform → Mkt Perform
2022-11-09 업그레이드 Barrington Research Mkt Perform → Outperform
2022-10-14 재개 Stephens Equal-Weight
2022-03-09 다운그레이드 Barrington Research Outperform → Mkt Perform
2022-03-09 다운그레이드 Stephens Overweight → Equal-Weight
2021-11-16 개시 Stephens Overweight
2021-07-16 개시 UBS Neutral
2020-12-16 업그레이드 Barrington Research Mkt Perform → Outperform
2020-05-08 다운그레이드 Barrington Research Outperform → Mkt Perform
2020-01-21 업그레이드 Sidoti Neutral → Buy
2020-01-10 업그레이드 First Analysis Sec Outperform → Strong Buy
2019-11-05 개시 BWS Financial Sell
2019-09-24 재확인 Barrington Research Outperform
2019-09-23 다운그레이드 First Analysis Sec Strong Buy → Outperform
2019-07-25 업그레이드 First Analysis Sec Neutral → Strong Buy
2019-02-22 다운그레이드 First Analysis Sec Outperform → Neutral
2019-02-22 다운그레이드 Sidoti Buy → Neutral
2018-07-27 업그레이드 Barrington Research Mkt Perform → Outperform
2018-06-20 다운그레이드 Barrington Research Outperform → Mkt Perform
2018-06-20 다운그레이드 First Analysis Sec Overweight → Equal-Weight
2018-05-04 업그레이드 Barrington Research Mkt Perform → Outperform
2018-02-23 다운그레이드 Barrington Research Outperform → Mkt Perform
2018-01-24 업그레이드 First Analysis Sec Equal-Weight → Overweight
2017-10-27 재확인 Barrington Research Outperform
2016-05-09 업그레이드 Singular Research BUY - Long-Term → Buy
2016-04-27 다운그레이드 Northland Capital Outperform → Market Perform
2016-02-26 재확인 Barrington Research Outperform
모두보기

Anika Therapeutics Inc 주식(ANIK)의 최신 뉴스

pulisher
12:34 PM

Anika Therapeutics (NASDAQ:ANIK) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

12:34 PM
pulisher
07:06 AM

What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 20252025 EndofYear Setup & Technical Pattern Based Signals - newser.com

07:06 AM
pulisher
06:32 AM

What dividend safety rating applies to Anika Therapeutics Inc. (AKP) stockTrade Ideas & Scalable Portfolio Growth Methods - newser.com

06:32 AM
pulisher
06:02 AM

Key metrics from Anika Therapeutics Inc.’s quarterly data2025 Winners & Losers & Verified Technical Signals - newser.com

06:02 AM
pulisher
05:28 AM

Is Anika Therapeutics Inc. stock supported by strong cash flows2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com

05:28 AM
pulisher
04:41 AM

Why Anika Therapeutics Inc. stock could rally in 2025Weekly Profit Analysis & Breakout Confirmation Alerts - newser.com

04:41 AM
pulisher
02:57 AM

Does Anika Therapeutics Inc. show high probability of reboundJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com

02:57 AM
pulisher
01:39 AM

Why Anika Therapeutics Inc. stock could outperform in 2025Bear Alert & Low Risk High Win Rate Stock Picks - newser.com

01:39 AM
pulisher
01:31 AM

Detecting support and resistance levels for Anika Therapeutics Inc.Inflation Watch & Long Hold Capital Preservation Plans - newser.com

01:31 AM
pulisher
Oct 30, 2025

Is Anika Therapeutics Inc. stock positioned for long term growthTrade Ideas & Risk Managed Investment Entry Signals - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Strategies to average down on Anika Therapeutics Inc.2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

How to escape a deep drawdown in Anika Therapeutics Inc.2025 Growth vs Value & Smart Allocation Stock Reports - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Anika Therapeutics, Inc. (NASDAQ:ANIK) is a favorite amongst institutional investors who own 60% - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Using AI based signals to follow Anika Therapeutics Inc.Quarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Anika Therapeutics Inc. stock sustain revenue growth2025 Momentum Check & Real-Time Price Movement Reports - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Will Anika Therapeutics Inc. (AKP) stock benefit from sector leadershipMarket Performance Report & Daily Technical Forecast Reports - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Can Anika Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Macro Moves & Fast Gain Swing Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Is Anika Therapeutics Inc. stock attractive for growth ETFsWeekly Gains Summary & Long-Term Safe Investment Ideas - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Anika Therapeutics’ Integrity Implant System Study: A Market Game Changer? - TipRanks

Oct 27, 2025

Anika Therapeutics Inc (ANIK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Anika Therapeutics Inc 주식 (ANIK) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
자본화:     |  볼륨(24시간):